Prolonged survival time of allografts by the oral administration of RDP58 linked to the cholera toxin B subunit

Transplant Immunology

Volumn 27, Issue 2-3, 2012, Pages 122-127

  Yu, Xuesong ^a   Song, Bo ^a   Huang, Chibing ^a   Xiao, Ya ^a   Fang, Mingqi ^a   Feng, Jiayu ^a   Wang, Pingxian ^a   Zhang, Genfu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cholera toxin B (CTB); Kidney transplantation; Oral administration; RDP58

Indexed keywords

CHOLERA TOXIN B SUBUNIT; DELMITIDE; HEME OXYGENASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GRAFT REJECTION; GRAFT SURVIVAL; HEME OXYGENASE-1; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KIDNEY TRANSPLANTATION; MALE; PEPTIDES; PERIPHERAL TOLERANCE; RATS; RATS, INBRED BN;

EID: 84868341089     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.06.004     Document Type: Article

References (26)

1. Clark D.J.U. HLA and kidney transplantation. J Clin Pathol 2010, 63:21-25.
2. Hauser I.A., Spiegler S., Kiss E., Gauer S., Sichler O., Scheuermann E.H., et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-r (MIG). J Am Soc Nephrol 2005, 16:1849-1858.
3. Stehling O., Grau V., Steiniger B. Monocyte cytotoxicity during acute kidney graft rejection in rats. Int Immunol 2004, 16:101-110.
4. Iyer S., Kontoyiannis D., Chevrier D., Woo J., Mori N., Cornejo M., et al. Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide. J Biol Chem 2000, 275:17051.
5. Grassy G., Calas B., Yasri A., Lahana R., Woo J., Iyer S., et al. Computer-assisted rational design of immunosuppressive compounds. Nat Biotechnol 1998, 16:748.
6. Cuturi M.C., Cristoph F., Woo J., Iyer S., Brouard S., Heslan J.M., et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol Med 1999, 5:820.
7. Iyer S., Lahana R., Buelow R. Rational design and development of RDP58. Curr Pharm Des 2002, 8:99.
8. Kutty R.K., Maines M.D. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 1981, 256:3956.
9. Ohring M.D.-M., Thurau S.R., Wildner G. Labrafil-A new adjuvant for peptide-specific oral tolerance in rat experimental autoimmune uveitis. Pharmacol Res 2008, 57:26-31.
10. Fariaa A.M.C., Marona R., Ficker S.M., Slavina A.J., Spahna T., Weiner H.L. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J Autoimmun 2003, 20:135-145.
11. DeVrya C.G., Valdez M., Gaoa L., Wanga J., Kotschb K., Volk H.-D. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 152:33-43.
12. D'Ambrosio A., Colucci M., Pugliese O., Quintieri F., Boirivant M. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. J Leukoc Biol 2008, 84:661-668.
13. Lavelle E.C., Jarnicki A., McNeela E., Armstrong M.E., Higgins S.C., Leavy O., et al. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J Leukoc Biol 2004, 75:756-763.
14. Carlsson J., Drevin H., Axen R. Protein thiolation and reversible protein-protein conjugation. Biochem J 1978, 173:723-737.
15. Deramaudt T.B., Da Silva J.-L., Remy P., Kappas A., Abraham N.G. Negative regulation of human heme oxygenase in microvessel endothelial cells by dexamethasone. Proc Soc Exp Biol Med 1999, 222:185-193.
16. Ricchetti G.A., Williams L.M., Foxwell B.M. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol 2004, 76:719-726.
17. Chen Y., McKenna G.J., Ong C., Mui A.L.-F., Chung S.W. Liver nonparenchymal cells involved in hyporesponsiveness induced by portal vein injection of alloantigen. Immunol Lett 2002, 81:1-11.
18. Xie X., Wan Y., Zhu Z., Zhang H., Xu J. Chloramphenicol improved expression of recombinant cholera toxin B subunit in Escherichia coli and its adjuvanticity. Chin Med J 2011, 124:2751-2755.
19. Schnitzler A.C., Burke J.M., Wetzler L.M. Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells. Infect Immun 2007, 75:3150-3159.
20. Bregenholt S., Wang M., Wolfe T., Hughes A., Baerentzen L., Dyrberg T., et al. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand J Immunol 2003, 57:432-438.
21. Coccia E.M., Remoli M.E., Di Giacinto C., Del Zotto B., Giacomini E., Monteleone G., et al. Cholera toxin subunit B inhibits IL-12 and IFN-{γ} production and signaling in experimental colitis and Crohn's disease. Gut 2005, 54:1558-1564.
22. Sun J.B., Czerkinsky C., Holmgren J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 2010, 71:1-11.
23. Bregenholt S., Wang M., Wolfe T., Hughes A., Bærentzen L., Dyrberg T., Von Herrath M.G., Petersen J.S. The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes. Scand J Immunol 2003, 57:432-438.
24. Li T.K., Fox B.S. Cholera toxin B subunit binding6 to an antigen presenting cell directly co-stimulates cytokine production from a T cell clone. Int Immunol 1996, 8:1849-1856.
25. Burkart V., Kim Y., Kauer M., Kolb H. Induction of tolerance in macrophages by cholera toxin B chain. Pathobiology 1999, 67:314-317.
26. Gong Z., Jin H., Jin Y., Zhang Y. Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm. J Biochem Mol Biol 2005, 38(6):717-724.